erythrosine has been researched along with Infarction, Middle Cerebral Artery in 26 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of ST1942, a 2-aminotetraline derivative with anti-inflammatory properties, was evaluated in ischemia/reperfusion injury in CD1 and C57BL/6 mice." | 3.74 | 2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window. ( Capone, C; Carminati, P; De Simoni, MG; Fabrizi, C; Fumagalli, L; Ghirardi, O; Marzorati, P; Piovesan, P; Principato, MC, 2007) |
| "Conivaptan is an FDA-approved vasopressin receptor antagonist that may exert both osmotic and anti-inflammatory effects." | 1.43 | The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke. ( Collier, L; Decker, D; Lau, T; Leonardo, C; Olivera, R; Pennypacker, KR; Roma, G; Rowe, D; Seifert, H, 2016) |
| "Permanent distal middle cerebral artery occlusion (dMCAO) was induced in rats by electrocoagulation." | 1.43 | [A method for combining Fluoro-Jade B staining and immunofluorescent staining]. ( Jin, JZ; Liu, DD; Sun, WW; Xu, E; Zuo, XL, 2016) |
| "Male Sprague-Dawley rats underwent middle cerebral artery occlusion, followed by intraperitoneal or intravenous treatment with yonkenafil starting 2h later." | 1.40 | Yonkenafil: a novel phosphodiesterase type 5 inhibitor induces neuronal network potentiation by a cGMP-dependent Nogo-R axis in acute experimental stroke. ( Chen, X; Liu, Y; Wang, N; Wang, Y; Wu, C; Yang, J; Zhang, T; Zhu, L, 2014) |
| "A brief 3-min middle cerebral artery occlusion (MCAO) was employed to induce IPC in male mice 72 h before 90-min MCAO." | 1.38 | Preconditioning induces sustained neuroprotection by downregulation of adenosine 5'-monophosphate-activated protein kinase. ( Benashski, SE; Li, J; McCullough, LD; Tarabishy, S; Venna, VR, 2012) |
| "Splenectomy prior to middle cerebral artery occlusion (MCAO) is neuroprotective and significantly reduces neuroinflammation." | 1.38 | The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling. ( Benkovic, SA; Collier, LA; Hall, AA; Leonardo, CC; Pennypacker, KR; Rowe, DD; Seifert, HA; Willing, AE, 2012) |
| "When we performed middle cerebral artery occlusion (MCAO) on adult mice, up-regulation of the receptor uncoordinated gene 5H2 (UNC5H2) but not its ligand netrin-1 was detected with RT-PCR and immunohistochemistry." | 1.35 | Netrin-1 attenuates ischemic stroke-induced apoptosis. ( Li, H; Li, WW; Wu, TW, 2008) |
| "1 h after middle cerebral artery occlusion resulted in a 59% reduction in the volume of infarction." | 1.33 | A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia. ( Almassian, B; Brady, RO; Chen, RW; Ghanbari, HA; Jiang, ZG; Lebowitz, MS; Lu, XC; Nelson, V; Pan, W; Tortella, FC; Yang, X, 2006) |
| "Rats were subjected to permanent embolic middle cerebral artery occlusion (MCAO) and allowed to recover before receiving subcutaneous injections of 15 mg/kg of DTG at 24, 48, and 72 hours." | 1.33 | Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. ( Ajmo, CT; Collier, L; Cuevas, J; Pennypacker, KR; Vernon, DO, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (57.69) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaire, BP | 1 |
| Song, MR | 1 |
| Choi, JW | 1 |
| Chen, X | 1 |
| Wang, N | 1 |
| Liu, Y | 2 |
| Zhang, T | 1 |
| Zhu, L | 1 |
| Wang, Y | 1 |
| Wu, C | 1 |
| Yang, J | 1 |
| Kwon, SK | 1 |
| Ahn, M | 1 |
| Song, HJ | 1 |
| Kang, SK | 1 |
| Jung, SB | 1 |
| Harsha, N | 1 |
| Jee, S | 1 |
| Moon, JY | 1 |
| Suh, KS | 1 |
| Lee, SD | 1 |
| Jeon, BH | 1 |
| Kim, DW | 1 |
| Kim, CS | 1 |
| Decker, D | 1 |
| Collier, L | 4 |
| Lau, T | 1 |
| Olivera, R | 1 |
| Roma, G | 1 |
| Leonardo, C | 1 |
| Seifert, H | 1 |
| Rowe, D | 1 |
| Pennypacker, KR | 6 |
| Zuo, XL | 1 |
| Jin, JZ | 1 |
| Liu, DD | 1 |
| Sun, WW | 1 |
| Xu, E | 1 |
| Wu, TW | 1 |
| Li, WW | 1 |
| Li, H | 1 |
| Glendenning, ML | 1 |
| Lovekamp-Swan, T | 1 |
| Schreihofer, DA | 1 |
| Liu, F | 1 |
| Schafer, DP | 1 |
| McCullough, LD | 2 |
| Chen, B | 1 |
| Friedman, B | 1 |
| Cheng, Q | 1 |
| Tsai, P | 1 |
| Schim, E | 1 |
| Kleinfeld, D | 1 |
| Lyden, PD | 1 |
| Ortolano, F | 1 |
| Maffia, P | 1 |
| Dever, G | 1 |
| Rodolico, G | 1 |
| Millington, OR | 1 |
| De Simoni, MG | 3 |
| Brewer, JM | 1 |
| Bushell, TJ | 1 |
| Garside, P | 1 |
| Carswell, HV | 1 |
| Moldovan, M | 1 |
| Constantinescu, AO | 1 |
| Balseanu, A | 1 |
| Oprescu, N | 1 |
| Zagrean, L | 1 |
| Popa-Wagner, A | 1 |
| Venna, VR | 1 |
| Li, J | 1 |
| Benashski, SE | 1 |
| Tarabishy, S | 1 |
| Arbeloa, J | 1 |
| Pérez-Samartín, A | 1 |
| Gottlieb, M | 1 |
| Matute, C | 1 |
| Seifert, HA | 2 |
| Leonardo, CC | 1 |
| Hall, AA | 2 |
| Rowe, DD | 1 |
| Collier, LA | 2 |
| Benkovic, SA | 1 |
| Willing, AE | 2 |
| Chapman, CB | 1 |
| Lee, JC | 1 |
| Cho, GS | 1 |
| Kim, HJ | 1 |
| Lim, JH | 1 |
| Oh, YK | 1 |
| Nam, W | 1 |
| Chung, JH | 1 |
| Kim, WK | 1 |
| Duckworth, EA | 2 |
| Butler, TL | 1 |
| De Mesquita, D | 1 |
| Collier, SN | 1 |
| Breuer, C | 1 |
| Wolf, G | 1 |
| Andrabi, SA | 1 |
| Lorenz, P | 1 |
| Horn, TF | 1 |
| Jiang, ZG | 1 |
| Lu, XC | 1 |
| Nelson, V | 1 |
| Yang, X | 1 |
| Pan, W | 1 |
| Chen, RW | 1 |
| Lebowitz, MS | 1 |
| Almassian, B | 1 |
| Tortella, FC | 1 |
| Brady, RO | 1 |
| Ghanbari, HA | 1 |
| Butler, T | 1 |
| Collier, S | 1 |
| Storini, C | 1 |
| Bergamaschini, L | 1 |
| Gesuete, R | 1 |
| Rossi, E | 1 |
| Maiocchi, D | 1 |
| Ajmo, CT | 1 |
| Vernon, DO | 1 |
| Cuevas, J | 1 |
| Benedek, A | 1 |
| Móricz, K | 1 |
| Jurányi, Z | 1 |
| Gigler, G | 1 |
| Lévay, G | 1 |
| Hársing, LG | 1 |
| Mátyus, P | 1 |
| Szénási, G | 1 |
| Albert, M | 1 |
| Capone, C | 1 |
| Fabrizi, C | 1 |
| Piovesan, P | 1 |
| Principato, MC | 1 |
| Marzorati, P | 1 |
| Ghirardi, O | 1 |
| Fumagalli, L | 1 |
| Carminati, P | 1 |
| Lei, ZN | 1 |
| Zhang, LM | 1 |
| Sun, FY | 1 |
| Rohn, TT | 1 |
| Vyas, V | 1 |
| Hernandez-Estrada, T | 1 |
| Nichol, KE | 1 |
| Christie, LA | 1 |
| Head, E | 1 |
26 other studies available for erythrosine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Sphingosine 1-phosphate receptor subtype 3 (S1P
Topics: Animals; Brain Injuries; Calcium-Binding Proteins; Cell Polarity; Cells, Cultured; Disease Models, A | 2018 |
Yonkenafil: a novel phosphodiesterase type 5 inhibitor induces neuronal network potentiation by a cGMP-dependent Nogo-R axis in acute experimental stroke.
Topics: Animals; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoresceins; GPI-Lin | 2014 |
Nafamostat mesilate attenuates transient focal ischemia/reperfusion-induced brain injury via the inhibition of endoplasmic reticulum stress.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Benzamidines; Br | 2015 |
The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Brain Edema; Disease Models | 2016 |
[A method for combining Fluoro-Jade B staining and immunofluorescent staining].
Topics: Animals; Brain; Fluoresceins; Fluorescent Antibody Technique; Fluorescent Dyes; Infarction, Middle C | 2016 |
Netrin-1 attenuates ischemic stroke-induced apoptosis.
Topics: Animals; Apoptosis; Brain Infarction; Cell Movement; Cells, Cultured; Cerebral Cortex; DCC Receptor; | 2008 |
Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats.
Topics: Animals; Behavior, Animal; Brain Infarction; Disease Models, Animal; Endothelin-1; Estrogens; Female | 2008 |
TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion.
Topics: Analysis of Variance; Animals; Brain; Brain Chemistry; Brain Infarction; DNA-Binding Proteins; Fluor | 2009 |
Severe blood-brain barrier disruption and surrounding tissue injury.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Cerebral Arteries; Dextrans; Disea | 2009 |
Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain.
Topics: Adoptive Transfer; Animals; Brain; Disease Models, Animal; Feasibility Studies; Female; Fluoresceins | 2010 |
Sleep deprivation attenuates experimental stroke severity in rats.
Topics: Animals; Caspase 3; Cerebral Infarction; Disease Models, Animal; Fluoresceins; Gait Disorders, Neuro | 2010 |
Preconditioning induces sustained neuroprotection by downregulation of adenosine 5'-monophosphate-activated protein kinase.
Topics: Animals; Brain; Brain Infarction; Disease Models, Animal; Down-Regulation; Fluoresceins; HSP72 Heat- | 2012 |
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Calcium; Cells, Cultured; Cer | 2012 |
The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.
Topics: Animals; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Female; Fluoresceins; Fluorescent Dyes; Immu | 2012 |
A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.
Topics: Animals; Cell Count; Cell Movement; Fluoresceins; Fluorescent Dyes; Immunohistochemistry; Infarction | 2012 |
Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum.
Topics: Animals; Brain Ischemia; Corpus Callosum; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Glutath | 2005 |
Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration.
Topics: Animals; Biomarkers; Brain; Brain Injuries; Cell Death; Cerebral Cortex; Corpus Striatum; Disease Mo | 2005 |
Blood-brain barrier permeability to the neuroprotectant oxyresveratrol.
Topics: Animals; Area Under Curve; Blood-Brain Barrier; CD11b Antigen; Cerebral Infarction; Chromatography, | 2006 |
A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.
Topics: Animals; Apoptosis; Blotting, Western; Calcium; Cerebral Cortex; Chelating Agents; Coculture Techniq | 2006 |
NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice.
Topics: Animals; beta-Galactosidase; Brain Injuries; Diagnostic Imaging; Fluoresceins; Functional Laterality | 2006 |
Selective inhibition of plasma kallikrein protects brain from reperfusion injury.
Topics: Animals; Behavior, Animal; Brain; Brain Edema; Cell Count; Cerebrovascular Disorders; Fluoresceins; | 2006 |
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Biomarkers; Brain; Brain Ischemia; Cell Survival | 2006 |
Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Coloring Agents; Evans Blue; Fluoresceins; Fluorescent Dyes; Indoles; Infar | 2006 |
2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window.
Topics: Amphetamines; Animals; Behavior, Animal; Brain Diseases; Cerebrovascular Circulation; CHO Cells; Cri | 2007 |
Beta-catenin siRNA inhibits ischemia-induced striatal neurogenesis in adult rat brain following a transient middle cerebral artery occlusion.
Topics: Animals; Animals, Newborn; beta Catenin; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell P | 2008 |
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Caspases; Dis | 2008 |